Trials / Completed
CompletedNCT02635880
A Clinical Evaluation of a Novel Multi-Wavelength Laser for Benign Pigmented Lesion Removal
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Cutera Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and efficacy of an investigational version of the Cutera enlightenTM laser that offers multiple wavelengths for removal of benign pigmented lesions.
Detailed description
The purpose of this investigation is to evaluate the safety and efficacy of an investigational version of the Cutera enlightenTM laser for benign pigmented lesion (BPL) removal. Currently, the enlightenTM laser offers two wavelengths: 532nm KTP and 1064nm Nd:YAG. The version of the laser under investigation allows the user to choose from a range of wavelengths.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Investigational Enlighten Device | Up to 3 laser treatments, spaced 4 to 6 weeks apart |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-02-01
- Completion
- 2016-03-23
- First posted
- 2015-12-21
- Last updated
- 2018-07-06
- Results posted
- 2018-07-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02635880. Inclusion in this directory is not an endorsement.